HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $61,686,285 | +36.9% | 1,084,118 | -4.8% | 7.80% | +35.3% |
| Q3 2022 | $45,043,000 | -32.9% | 1,139,170 | -25.4% | 5.76% | -24.9% |
| Q2 2022 | $67,157,000 | +8.9% | 1,526,293 | -1.3% | 7.67% | +41.8% |
| Q1 2022 | $61,678,000 | +2.3% | 1,546,592 | +3.1% | 5.41% | +12.2% |
| Q4 2021 | $60,298,000 | -1.6% | 1,499,576 | -0.5% | 4.82% | -6.0% |
| Q3 2021 | $61,283,000 | -0.1% | 1,506,473 | +11.5% | 5.13% | +1.3% |
| Q2 2021 | $61,343,000 | +8.7% | 1,350,870 | -0.2% | 5.06% | +0.7% |
| Q1 2021 | $56,415,000 | +13.5% | 1,353,208 | +16.3% | 5.03% | +9.2% |
| Q4 2020 | $49,709,000 | +74.5% | 1,163,881 | +7.4% | 4.60% | +50.1% |
| Q3 2020 | $28,488,000 | +6.1% | 1,084,015 | +8.2% | 3.07% | -1.3% |
| Q2 2020 | $26,849,000 | – | 1,001,447 | – | 3.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |